Topical CP-690,550 For Chronic Plaque Psoriasis

Completed · Phase 2 · Has a placebo group

Conditions studied: Psoriasis

In brief

Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.

Key facts

Study ID

NCT00678561

Run by

Pfizer

People needed

81

Starts

2008-10-13

Expected to finish

2009-07-24

Last updated by the study team

2020-12-31

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Having chronic plaque psoriasis for at least 6 months
• Able to withdraw all prior psoriasis treatments
• Must agree to avoid prolonged exposure to the sun and avoid use of tanning booths or other ultraviolet light sources during the study

You may not qualify if…

• Evidence of active, latent, or inadequately treated infection with Mycobacterium tuberculosis
• Pregnant or lactating women
• Unwilling to use appropriate contraceptive methods

Where it is running

• University of California Irvine — Irvine, California, United States
• Therapeutics Clinical Research — San Diego, California, United States
• RUSH University Medical Center — Chicago, Illinois, United States
• Tufts Medical Center — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Minnesota Clinical Study Center — Fridley, Minnesota, United States
• Central Dermatology, PC — St Louis, Missouri, United States
• Dermatology Consulting Services — High Point, North Carolina, United States
• The Imaging Center — High Point, North Carolina, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
• Oregon Medical Research Center, PC — Portland, Oregon, United States
• Oregon Health & Science University — Portland, Oregon, United States
• DermResearch, Inc. — Austin, Texas, United States
• University of Utah School of Medicine — Salt Lake City, Utah, United States
• Guildford Dermatology Specialists — Surrey, British Columbia, Canada
• NewLab Clinical Research Inc. — St. John's, Newfoundland and Labrador, Canada
• K.Papp Clinical Research Inc. — Waterloo, Ontario, Canada
• Innovaderm Research, Inc. — Montreal, Quebec, Canada
• Siena Medical Research — Montreal, Quebec, Canada
• Centre de Recherche Dermatologique du Quebec metropolitain — Québec, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.